| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |